VEGF is an essential mediator of the neurogenic and behavioral actions of antidepressants
Open accessThe DOI matches its Crossref record; 56 of the 56 references it cites were found in a registry or an index.
Abstract
The neural mechanisms underlying the cellular and behavioral responses to antidepressants are not yet known. Up-regulation of growth factors and adult neurogenesis suggest a role for one or more of these factors in the action of antidepressants. One candidate of interest is vascular endothelial growth factor (VEGF), which was initially characterized for its role in angiogenesis, but also exerts direct mitogenic effects on neural progenitors in vitro . Results of this study demonstrate that VEGF is induced by multiple classes of antidepressants at time points consistent with the induction of cell proliferation and therapeutic action of these treatments. We find that VEGF signaling through the Flk-1 receptor is required for antidepressant-induced cell proliferation. We also show that VEGF-Flk-1 signaling is required and sufficient for behavioral responses in two chronic and two subchronic antidepressant models. Taken together, these studies identify VEGF and VEGF-Flk-1 signaling as mediators of antidepressant actions and potential targets for therapeutic intervention.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In a similar manner, VEGF also seems to be required for the behavioral action of various antidepressant drugs in rodent models of depression (Greene et al. 2009; Sun et al. 2012; Warner-Schmidt and Duman 2007; Warner-Schmidt and Duman 2008).”
From Neurotrophic factors and neuroplasticity pathways in the pathophysiology and treatment of depression (2018) · cites this paper as Warner-Schmidt and Duman 2007
Citations
Cites
Kessler, R. C. (1994) · Archives of General Psychiatry · doi:10.1001/archpsyc.1994.03950010008002 · Cited by 12,370
The biology of VEGF and its receptors
Ferrara, N., Gerber, H.-P., & LeCouter, J. (2003) · Nature Medicine · doi:10.1038/nm0603-669 · Cited by 9,591
Requirement of hippocampal neurogenesis for the behavioral effects of antidepressants
Santarelli, L., Saxe, M., Gross, C., Surget, A., Battaglia, F., Dulawa, S., Weisstaub, N., Lee, J., Duman, R., Arancio, O., et al. (2003) · Science · doi:10.1126/science.1083328 · Cited by 4,321
Self-citationKuhn, H., Dickinson-Anson, H., & Gage, F. (1996) · The Journal of Neuroscience · doi:10.1523/jneurosci.16-06-02027.1996 · Cited by 3,139
Chronic antidepressant treatment increases neurogenesis in adult rat hippocampus
Malberg, J. E., Eisch, A. J., Nestler, E. J., & Duman, R. S. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-24-09104.2000 · Cited by 3,111
Self-citationNibuya, M., Morinobu, S., & Duman, R. (1995) · The Journal of Neuroscience · doi:10.1523/jneurosci.15-11-07539.1995 · Cited by 2,109
Self-citationThe fms -Like Tyrosine Kinase, a Receptor for Vascular Endothelial Growth Factor
de Vries, C., Escobedo, J. A., Ueno, H., Houck, K., Ferrara, N., & Williams, L. T. (1992) · Science · doi:10.1126/science.1312256 · Cited by 2,016
Willner, P., Towell, A., Sampson, D., Sophokleous, S., & Muscat, R. (1987) · Psychopharmacology · doi:10.1007/bf00187257 · Cited by 1,993
Vascular niche for adult hippocampal neurogenesis
Palmer, T. D., Willhoite, A. R., & Gage, F. H. (2000) · The Journal of Comparative Neurology · doi:10.1002/1096-9861(20001002)425:4<479::aid-cne2>3.0.co;2-3 · Cited by 1,838
Brain-derived neurotrophic factor produces antidepressant effects in behavioral models of depression
Shirayama, Y., Chen, A. C.-H., Nakagawa, S., Russell, D. S., & Duman, R. S. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-08-03251.2002 · Cited by 1,654
Self-citation
Research works printed but not linked: 6
- TA Fong, LK Shawver, L Sun, C Tang, H App, TJ Powell, YH Kim, R Schreck, X Wang, W Risau, et al. Cancer Res 59, 99–106 (1999).
- DB Mendel, AD Laird, BD Smolich, RA Blake, C Liang, AL Hannah, RM Shaheen, LM Ellis, S Weitman, LK Shawver, JM Cherrington Anticancer Drug Des 15, 29–41 (2000).
- LM Strawn, G McMahon, H App, R Schreck, WR Kuchler, MP Longhi, TH Hui, C Tang, A Levitzki, A Gazit, et al. Cancer Res 56, 3540–3545 (1996).
- P Tapley, F Lamballe, M Barbacid Oncogene 7, 371–381 (1992).
- AM Duijvestijn, H van Goor, F Klatter, GD Majoor, E van Bussel, PJ van Breda Vriesman Lab Invest 66, 459–466 (1992).
- M Banasr, GW Valentine, XY Li, S Gourley, J Taylor, RS Duman Biol Psychiatry, in press. (2006).
Cited by
Items 301–400 of 452
Vascular endothelial growth factor: a key factor in the onset and treatment of depression
Wang, J., Meng, F., Wang, L., & Li, Z. (2025) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2025.1645437 · Cited by 17
Guo, X., Wang, M., Wang, X., Guo, M., Xue, T., Wang, Z., Li, H., Xu, T., He, B., Cui, D., et al. (2021) · Cerebral Cortex · doi:10.1093/cercor/bhab453 · Cited by 17
Psychological stress impairs ischemia-induced neovascularization: Protective effect of fluoxetine
Maingrette, F., Dussault, S., Dhahri, W., Desjarlais, M., Mathieu, R., Turgeon, J., Haddad, P., Groleau, J., Pérez, G., & Rivard, A. (2015) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2015.06.010 · Cited by 17
Lee, H., Nagata, K., Nakajima, S., Ohno, M., Ohta, S., & Mikami, T. (2018) · Behavioural Brain Research · doi:10.1016/j.bbr.2018.01.017 · Cited by 19
Genetic comorbidity of depression and somatic disorders
Rukavishnikov, G. V., Kibitov, A. O., Mazo, G. E., & Незнанов, Н. Г. (2019) · S S Korsakov Journal of Neurology and Psychiatry · doi:10.17116/jnevro201911901189 · Cited by 16
Rossi, G. N., Hallak, J. E. C., Baker, G. B., Dursun, S. M., & SANTOS, R. G. D. (2022) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-022-01460-2 · Cited by 16
Lizano, P. L., Lutz, O., Ling, G., Padmanabhan, J. L., Tandon, N., Sweeney, J. A., Tamminga, C. A., Pearlson, G. D., Ruaño, G., Kocherla, M., et al. (2018) · Translational Psychiatry · doi:10.1038/s41398-018-0271-y · Cited by 16
Yue, Y., Jiang, H., Liu, R., Yin, Y., Zhang, Y., Liang, J., Li, S., Wang, J., Lü, J., Geng, D., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.11105 · Cited by 15
Mitsumori, T., Furuyashiki, T., Momiyama, T., Nishi, A., Shuto, T., Hayakawa, T., Ushikubi, F., Kitaoka, S., Aoki, T., Inoue, H., et al. (2011) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2011.07774.x · Cited by 18
Autocrine VEGF drives neural stem cell proximity to the adult hippocampus vascular niche
Dause, T. J., Denninger, J. K., Osap, R., Walters, A. E., Rieskamp, J. D., Kuwahara, A. A., & Kirby, E. D. (2024) · Life Science Alliance · doi:10.26508/lsa.202402659 · Cited by 14
Antidepressant hyperforin up-regulates VEGF in CNS tumour cells
Tassone, E., Maran, C., Masola, V., Bradaschia, A., Garbisa, S., & Onisto, M. (2010) · Pharmacological Research · doi:10.1016/j.phrs.2010.09.005 · Cited by 14
Antidepressant-induced vascular dynamics in the hippocampus of adult mouse brain
Mannari, T., Sawa, H., Furube, E., Fukushima, S., Nishikawa, K., Nakashimna, T., & Miyata, S. (2014) · Cell and Tissue Research · doi:10.1007/s00441-014-1933-6 · Cited by 14
Eszopiclone and fluoxetine enhance the survival of newborn neurons in the adult rat hippocampus
Su, X., Li, X., Banasr, M., & Duman, R. S. (2009) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145709990629 · Cited by 14
Self-citationThe hygiene hypothesis and affective and anxiety disorders
Rook, G. A. W., & Lowry, C. A. (2009) · Birkhäuser Basel eBooks · doi:10.1007/978-3-7643-8903-1_11 · Cited by 17
Zheng, W., Gu, L.-M., Zhou, Y.-L., Wang, C.-Y., Lan, X.-F., Zhang, B., Shi, H.-S., Wang, D.-F., & Ning, Y.-P. (2021) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2021.780975 · Cited by 12
“VEGF also appeared to be critical for the behavioral effects of various antidepressants (20, 34, 35) and lamotrigine (36) in rodent models of depression.”
BackgroundAshbrook, D. G., Delprato, A., Grellmann, C., Klein, M., Wetzel, R., Overall, R. W., & Badea, A. (2014) · Frontiers in Neuroscience · doi:10.3389/fnins.2014.00418 · Cited by 14
Jahromi, M., Razavi, S., Amirpour, N., & Khosravizadeh, Z. (2016) · PubMed Central · Cited by 14
Serotonin - Neurotransmitter and Hormone of Brain, Bowels and Blood
Fatima-Shad, K. (2023) · IntechOpen eBooks · doi:10.5772/intechopen.1000435 · Cited by 11
Serotonin reuptake inhibitors improve muscle stem cell function and muscle regeneration in male mice
Fefeu, M., Blatzer, M., Kneppers, A. E. M., Briand, D., Rocheteau, P., Haroche, A., Hardy, D., Juchet-Martin, M., Danckaert, A., Coudoré, F., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-50220-4 · Cited by 11
Serum level of vascular endothelial growth factor decreased in chronic ketamine abusers
Fan, N., Zhang, M., Xu, K., Ke, X., Ding, Y., Wang, D., Liu, Y., Ning, Y., Deng, X., & He, H. (2015) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2015.04.022 · Cited by 11
Zheng, W., Zhou, Y., Wang, C., Lan, X., Zhang, B., Zhou, S., Yan, S., Yang, M., Nie, S., & Ning, Y. (2021) · Therapeutic Advances in Psychopharmacology · doi:10.1177/20451253211014320 · Cited by 11
Neurotrophic Factors and Antidepressant Action: Recent Advances
O’Leary, O. F., & Ċastrén, E. (2010) · Modern trends in psychiatry · doi:10.1159/000319514 · Cited by 13
Neurobiology of Mood Disorders
Manchia, M., & Schatzberg, A. F. (2024) · Springer eBooks · doi:10.1007/978-3-030-51366-5_83 · Cited by 11
Otsubo, K., Sakashita, N., Nishimoto, Y., Sato, Y., Tsutsui, T., Kobayashi, K., Suzuki, K., & Segi‐Nishida, E. (2024) · Frontiers in Neuroscience · doi:10.3389/fnins.2024.1418058 · Cited by 10
Antidepressants in the treatment of stroke
Burns, M. M. J., & Greenberg, D. A. (2010) · Expert Review of Neurotherapeutics · doi:10.1586/ern.10.96 · Cited by 11
Roslavtceva, V., Salmina, A. B., Prokopenko, S. V., Пожиленкова, Е. А., Кобаненко, И. В., & Rezvitskaya, G. G. (2016) · Biomeditsinskaya Khimiya · doi:10.18097/pbmc20166202124 · Cited by 14
Rigal, A., Colle, R., Asmar, K. E., Trabado, S., Loeb, E., Martin, S., Choucha, W., Gressier, F., Costemale-Lacoste, J.-F., de Larminat, D., et al. (2019) · Australian & New Zealand Journal of Psychiatry · doi:10.1177/0004867419893433 · Cited by 12
An, X., & Wang, Y. (2022) · Psychiatry Research · doi:10.1016/j.psychres.2022.114390 · Cited by 11
Gliozzi, M., Coppoletta, A. R., Cardamone, A., Musolino, V., Carresi, C., Nucera, S., Ruga, S., Scarano, F., Bosco, F., Guarnieri, L., et al. (2024) · Pharmacological Research · doi:10.1016/j.phrs.2024.107087 · Cited by 9
Desvenlafaxine May Accelerate Neuronal Maturation in the Dentate Gyri of Adult Male Rats
Asokan, A., Ball, A. R., Laird, C. D., Hermer, L., & Ormerod, B. K. (2014) · PLoS ONE · doi:10.1371/journal.pone.0098530 · Cited by 10
Multitarget botanical pharmacotherapy in major depression: a toxic brain hypothesis
Tang, S. W., Tang, W. H., & Leonard, B. E. (2017) · International Clinical Psychopharmacology · doi:10.1097/yic.0000000000000186 · Cited by 9
Ma, K., Wilson, C., Hannan, A. J., & Renoir, T. (2020) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2020.172940 · Cited by 9
Ledesma‐Corvi, S., & García-Fuster, M. J. (2022) · Pharmacological Reports · doi:10.1007/s43440-022-00372-1 · Cited by 8
Samaddar, S., Ranasinghe, B., Tantry, S. J., Debata, P. R., & Banerjee, P. (2014) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-11280-0_23 · Cited by 8
Encapsulated stem cells ameliorate depressive-like behavior via growth factor secretion
Yasuhara, T., Kin, K., Borlongan, C., & Date, I. (2018) · Brain Circulation · doi:10.4103/bc.bc_17_18 · Cited by 8
Kim, J., Park, J.-H., & Mikami, T. (2022) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2022.866405 · Cited by 9
Yue, Y., You, L., Zhao, F., Zhang, K., Shi, Y., Tang, H., Lü, J., Li, S., Cao, J.-X., Geng, D., et al. (2023) · General Psychiatry · doi:10.1136/gpsych-2022-100928 · Cited by 9
Kawasaki, Y., Fujiki, M., Uchida, S., Morishige, M., Momii, Y., & Ishii, K. (2017) · Pathobiology · doi:10.1159/000452862 · Cited by 8
Genetics and Neurobiology of Treatment-Resistant Depression—A Review
Płaza, O., Gałecki, P., Bliźniewska-Kowalska, K. M., Gałecka, M., Brońska, A., Jornet-Plaza, J., Szurek, A., & Szulc, A. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms262211016 · Cited by 8
Boldrini, M., & Mann, J. J. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-85654-6.00039-3 · Cited by 9
The rat hippocampal gliovascular system following one week vortioxetine and fluoxetine
Chen, F., Danladi, J., Ardalan, M., Nyengaard, J. R., Sánchez, C., & Wegener, G. (2020) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2020.11.008 · Cited by 7
Serum angioneurin levels following electroconvulsive therapy for mood disorders
Zhang, T., Tang, X., Wei, Y., Xu, L., Hu, Y., Cui, H., Zeng, J., Ye, J., Xie, Y., Tang, Y., et al. (2023) · Bipolar Disorders · doi:10.1111/bdi.13317 · Cited by 7
Mayegowda, S. B., Rao, B. V., & Rao, B. S. R. S. (2024) · Journal of Applied Pharmaceutical Science · doi:10.7324/japs.2024.158094 · Cited by 10
Royds, J., Cassidy, H., Conroy, M. J., Dunne, M. R., Lysaght, J., & McCrory, C. R. (2020) · Brain Behavior & Immunity - Health · doi:10.1016/j.bbih.2020.100184 · Cited by 9
Deyama, S., Li, X., & Duman, R. S. (2023) · Neuropsychopharmacology Reports · doi:10.1002/npr2.12393 · Cited by 6
Self-citationNeuroprotective effect of escitalopram oxalate in rats with chronic hypoperfusion
Ma, L., Lu, Z., Hu, P. L., & Yao, C. (2015) · Journal of Huazhong University of Science and Technology [Medical Sciences] · doi:10.1007/s11596-015-1462-x · Cited by 6
Protein Kinase D was involved in vascular remodeling in spontaneously hypertensive rats
Geng, J., Zhao, Z., Yang, L. J., Zhang, M., & Liu, X. (2018) · Clinical and Experimental Hypertension · doi:10.1080/10641963.2018.1469647 · Cited by 6
Food restriction does not relieve PTSD-like anxiety
Hendriksen, H., Bink, D. I., Vergoossen, D. L. E., van Slobbe, E. S., Olivier, B., & Oosting, R. S. (2014) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2014.10.060 · Cited by 5
Becker, M., Abaev, K., Pinhasov, A., & Ornoy, A. (2022) · Behavioural Brain Research · doi:10.1016/j.bbr.2022.113866 · Cited by 5
Zhang, P., Guan, J., Zhang, N., Zhu, L., Wang, Y. T., Li, W., Shi, Z., Liu, X., Li, X., Qin, M., et al. (2023) · NPG Asia Materials · doi:10.1038/s41427-023-00505-9 · Cited by 5
Neurogenic hypothesis and psychiatric disorders
Lau, B. W.-M., Lee, J. C.-D., & So, K. (2013) · Chinese Science Bulletin · doi:10.1007/s11434-013-5886-z · Cited by 8
Burke, S. D. A. (2025) · American Journal of Human Biology · doi:10.1002/ajhb.70146 · Cited by 4
Kaushik, R., Nayak, B., Satapathy, S. S., Bharti, D. R., Pandey, S., & Behera, C. (2024) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2024.107268 · Cited by 4
Mantel, I., Zola, M., Mir, O., Gaillard, R., & Béhar‐Cohen, F. (2018) · British Journal of Ophthalmology · doi:10.1136/bjophthalmol-2018-312318 · Cited by 4
Kucharska–Mazur, J., Ratajczak, M. Z., & Samochowiec, J. (2019) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-31206-0_8 · Cited by 4
Neurophysiological Effects of Exercise
Cırrık, S., & Hacıoğlu, G. (2016) · InTech eBooks · doi:10.5772/64801 · Cited by 4
Schoenfeld, T. J., & Gould, E. (2011) · Wiley eBooks · doi:10.1002/9781118083222.ch7 · Cited by 4
Elfving, B., Liebenberg, N., du Jardin, K. G., Sánchez, C., Wegener, G., & Müller, H. K. (2022) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2022.10.011 · Cited by 4
Sertraline-induced increase in VEGF brain levels and its activity in cryptococcal meningitis
Loulergue, P., Mir, O., Rocheteau, P., Chrétien, F., & Gaillard, R. (2016) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(16)30147-5 · Cited by 4
The inhibition of phosphodiesterase type 5 as a novel target for antidepressant action
Liebenberg, N. (2009) · Cited by 5
Epigenetic regulation of BDNF-TrkB signaling in the pathophysiology and treatment of mood disorders
Boulle, F. (2013) · Research Publications (Maastricht University) · doi:10.26481/dis.20131129fb · Cited by 8
Methylone promotes neurite outgrowth and has long-lasting effects on fear extinction learning
Warner‐Schmidt, J. L., Stogniew, M., Mandell, B., & Kelmendi, B. (2025) · Neuropsychopharmacology · doi:10.1038/s41386-025-02206-z · Cited by 4
Self-citationAntidepressant-like effects of trophic factor receptor signaling
Sathyanesan, M., & Newton, S. S. (2022) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2022.958797 · Cited by 4
Dause, T. J., Osap, R., Kuwahara, A. A., Denninger, J. K., & Kirby, E. D. (2025) · Molecular Neurobiology · doi:10.1007/s12035-025-04861-1 · Cited by 3
Neurogenic Basis of Antidepressant Action: Recent Advances
Tanti, A., & Belzung, C. (2010) · Modern trends in psychiatry · doi:10.1159/000319515 · Cited by 3
Glycogen Synthase Kinase-3 in Neurological Diseases
Kaidanovich‐Beilin, O., & Woodgett, J. R. (2012) · Neuromethods · doi:10.1007/978-1-61779-824-5_9 · Cited by 3
Neuroadaptations of the 5-HT System Induced by Antidepressant Treatments: Old and New Strategies
Haddjeri, N. (2014) · Addiction & Addictive Disorders · doi:10.24966/aad-7276/100001 · Cited by 3
Thornton, O. R. (2023) · International Neuropsychiatric Disease Journal · doi:10.9734/indj/2023/v20i3399 · Cited by 3
Maltsev, D. I., Aniol, V. A., Golden, M., Petrina, A. D., Belousov, V. V., Gulyaeva, N. V., & Podgorny, O. V. (2023) · Molecular Neurobiology · doi:10.1007/s12035-023-03746-5 · Cited by 3
Depressive Disorders: Prevalence, Costs, and Theories
Grosso, C., Valentão, P., & Andrade, P. B. (2016) · Springer eBooks · doi:10.1007/978-3-319-14021-6_1 · Cited by 4
Perspectives for an Integrated Biomarker Approach to Drug Discovery and Development
Antonijevic, I. A., Artymyshyn, R. P., Forray, C., Rabacchi, S. A., Smith, K. E., Swanson, C. J., Tamm, J. A., Mazin, W., & Gerald, C. (2008) · Springer eBooks · doi:10.1007/978-0-387-79251-4_15 · Cited by 4
Quiroz, J. A., Chen, G., Drevets, W. C., Henter, I. D., & Manji, H. K. (2012) · Cambridge University Press eBooks · doi:10.1017/cbo9780511980053.004 · Cited by 5
Neurogenic factors are targets in depression
Taupin, P. (2008) · Drug Discovery Today Therapeutic Strategies · doi:10.1016/j.ddstr.2008.09.002 · Cited by 3
Diagnosis of Major Depressive Disorders: Clinical and Biological Perspectives
Fakhoury, M. (2017) · Springer eBooks · doi:10.1007/978-981-10-6577-4_4 · Cited by 5
Physical Exercise Benefits Cognition: A Narrative Review of Evidence and Possible Mechanisms
Wang, T.-F., Mee-inta, O., & Kuo, Y. (2025) · Advances in neurobiology · doi:10.1007/978-981-95-0066-6_7 · Cited by 2
Ibrahim, D., Peț, I., Sherkawy, H. S., Eldoumani, H., Fathy, O. M., Elgamal, A., Gharib, H. S. A., Muhammed, A. A., Metwally, A. S., Ahmadi, M., et al. (2025) · Frontiers in Pharmacology · doi:10.3389/fphar.2025.1621092 · Cited by 2
Promising Role of Vascular Endothelial Growth Factor-A in Risk Stratification after PCI
Petyunina, O. V., Kopytsya, M. P., Rudyk, I. S., & Isayeva, G. (2019) · IntechOpen eBooks · doi:10.5772/intechopen.82712 · Cited by 2
Bonea, M., Coroama, C.-I., Popp, R. A., & Micluția, I. (2023) · Archives of Industrial Hygiene and Toxicology · doi:10.2478/aiht-2023-74-3690 · Cited by 3
Briones-Aranda, A., Corzo-Gómez, J. C., Casique‐Aguirre, D., & Megchún-Hernández, M. (2023) · IntechOpen eBooks · doi:10.5772/intechopen.1003630 · Cited by 2
Can Stem Cells Be Used to Enhance Cognition?
Goldberg, N. R. S., & Blurton-Jones, M. M. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-417042-1.00008-5 · Cited by 2
Ramírez-Rodríguez, G. B., Laguna-Chimal, J., Vega‐Rivera, N. M., Ortíz‐López, L., Méndez-Cuesta, L. A., Estrada-Camarena, E. M., & Babu, H. (2011) · Salud Mental · Cited by 3
Role of Adult Neurogenesis in Seizure-Induced Hippocampal Remodeling and Epilepsy
Althaus, A. L., & Parent, J. M. (2014) · Stem cell biology and regenerative medicine · doi:10.1007/978-1-4899-7399-3_5 · Cited by 2
Tomita, T., Yasui‐Furukori, N., Tsuchimine, S., Kaneda, A., & Kaneko, S. (2013) · Neuropsychobiology · doi:10.1159/000356233 · Cited by 2
Brem, S. S., & Wong, E. T. (2011) · Elsevier eBooks · doi:10.1016/b978-1-4160-5316-3.00106-4 · Cited by 2
Schneider, C., & Wissink, T. (2017) · Elsevier eBooks · doi:10.1016/b978-0-323-35868-2.00005-0 · Cited by 2
From non-pharmacological interventions to therapeutic targets for the treatment of PTSD
Hendriksen, H. M. A. (2012) · Utrecht University Repository (Utrecht University) · Cited by 2
Klempin, F. (2008) · edoc Publication server (Humboldt University of Berlin) · doi:10.18452/15844 · Cited by 3
Levy, M. J. F. (2017) · theses.fr (ABES) · doi:10.70675/be792343za725z4b2czb8c5z8a26a8113d23 · Cited by 3
Soluble vascular endothelial growth factor receptor 1 (VEGFR1): A possible biomarker in BPS/IC?
Abreu‐Mendes, P., Pinto, R. A., Dias, D., Cruz, F., & Charrua, A. (2025) · Continence · doi:10.1016/j.cont.2025.101898 · Cited by 1
Dyndał, K., Pańczyszyn-Trzewik, P., Jakubowska, B., & Sowa-Kućma, M. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27052449 · Cited by 2
Kashiwabara, R., Suzuki, H., Waguri, I., Akimoto, N., Miura, K., Tsutsui, T., Suzuki, K., & Segi‐Nishida, E. (2026) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.b25-00825 · Cited by 1
Biomarker in der Depressionsbehandlung: mehr als nur Worte?
Bosch, O. G., & Breitenstein, B. (2015) · Zeitschrift für Psychiatrie Psychologie und Psychotherapie · doi:10.1024/1661-4747/a000244 · Cited by 3
Roslavtceva, V., Salmina, A. B., Prokopenko, S. V., Пожиленкова, Е. А., Кобаненко, И. В., & Rezvitskaya, G. G. (2016) · Biochemistry (Moscow) Supplement Series B Biomedical Chemistry · doi:10.1134/s1990750816040053 · Cited by 1
Nakagawa, S., & Duman, R. S. (2011) · Springer eBooks · doi:10.1007/978-4-431-53945-2_5 · Cited by 2
Self-citationKempermann, G. (2010) · Oxford University Press eBooks · doi:10.1093/med/9780199729692.003.0009 · Cited by 2
Ращупкин, И. М., Amstislavskaya, T. G., Markova, E. V., Ostanin, A. A., & Shevela, Е. Y. (2023) · Medical Immunology (Russia) · doi:10.15789/1563-0625-eos-2731 · Cited by 1
Uzuneser, T. C., Jones, M. J., Sarikahya, M. H., Gummerson, D., Whitehead, S. N., Hardy, D. B., Rushlow, W. J., & Laviolette, S. R. (2025) · Neurobiology of Disease · doi:10.1016/j.nbd.2025.107201 · Cited by 1
An unexpected role for fibroblast growth factor-2 in modulating anxiety and hippocampal stem cells
Pérez, J. A. (2008) · Deep Blue (University of Michigan) · Cited by 1
Cazzella, T., Fortaner‐Uyà, L., Paolini, M., Percaccioli, C., Colombo, F., Venturelli, E., Colombo, C., Zanardi, R., Spadini, S., Lorenzi, C., et al. (2026) · Psychiatry and Clinical Neurosciences · doi:10.1111/pcn.70144
Examining reelin expression and neural plasticity in animal models of depression
Lussier, A. L. (2012) · University Library - University of Saskatchewan (University of Saskatchewan)
Metadata
- Authors
- Warner-Schmidt, J. L., & Duman, R. S.
- Affiliations
- Departments of Psychiatry and Pharmacology, Yale University School of Medicine, New Haven, CT 06508
- Johns Hopkins University (US)
- Corresponding author
- Duman, Ronald S.
- ORCID
- Duman, Ronald S.
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 2007-03-13
- Volume
- 104
- Issue
- 11
- Pages
- 4647-4652
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC1838655
- OpenAlex
- W2048398100
- Cited by
- 438
- References
- 56
- Citations by year
- 2026: 8 · 2025: 12 · 2024: 9 · 2023: 14 · 2022: 17 · 2021: 11 · 2020: 15 · 2019: 18 · 2018: 19 · 2017: 15 · 2016: 23 · 2015: 30 · 2014: 32 · 2013: 33 · 2012: 38
- FWCI
- 10.05
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- U.S. Public Health Service (MH45481)
- National Institute of Mental Health (MH 25642, MH-45481, R37MH045481, P01MH025642, R01MH045481)
- Topics
- Life Sciences › Neuroscience › Developmental Neuroscience › Neurogenesis and neuroplasticity mechanisms
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Keywords
- vascular endothelial growth factor, antidepressants, adult neurogenesis, neural progenitor proliferation, VEGF signaling, growth factors
- MeSH terms
- Animals, Antidepressive Agents, Behavior, Animal, Brain, Electroshock, Male, Neovascularization, Pathologic, Neurons, Signal Transduction, Rats, Sprague-Dawley, Vascular Endothelial Growth Factor Receptor-2, Vascular Endothelial Growth Factor A, Cell Proliferation, Mice, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.